Skip to main content
SpringerLink
Log in

Differentiated Thyroid Cancer in Children

  • Chapter
Thyroid Cancer in Clinical Practice

  • 906 Accesses

Abstract

Thyroid cancer arising from the follicular cells in children is rare and few physicians have experience with its diagnosis and management. Also, few surgeons are trained in conducting thyroidectomies in children. There are some differences in thyroid cancer in children compared with adults. The cancers in pediatric patients are almost all papillary and more advanced. The primary cancer is often larger than in adults plus multifocality and local invasion are more common as are metastases to cervical lymph nodes and distant metastases to the lungs. The recurrence rate is also higher. Complications of treatment are more common and have to be lived with for many decades. The parents want to know the implications of the disease and treatments on longevity, fertility, and unborn grandchildren. The doctor needs to be constantly there for the patient and family. The role of radiation and genetics as causal factors was presented in Chapter 1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wu Y. Differentiated carcinoma of the thyroid in children and adolescents. Ann Chir 2001;126(10):977–980.

    Article  CAS  PubMed  Google Scholar 

  2. Farahati J, Parlowsky T, Mader U, Reiners C, Bucsky P. Differentiated thyroid cancer in children and adolescents. Langenbecks Arch Surg 1998;383(3–4):235–239.

    Article  CAS  PubMed  Google Scholar 

  3. De Keyser LF, Van Herle AJ. Differentiated thyroid cancer in children. Head Neck Surg 1985;8(2):100–114.

    Article  PubMed  Google Scholar 

  4. Nagai G, Pitts W, Basso L, Cisco JA, McDougall IR. Scintigraphic “hot nodules” and thyroid carcinoma. Clin Nucl Med 1987;12:123–127.

    Article  CAS  PubMed  Google Scholar 

  5. Corrias A, Einaudi S, Chiorboli E, et al. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab 2001;86:4484–4488.

    Article  Google Scholar 

  6. La Quaglia MP, Black T, Holcomb GW 3rd, et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children’s Cancer Group. J Pediatr Surg 2000;35(6):955–959; discussion 960.

    Article  PubMed  Google Scholar 

  7. Peretz A, Leiberman E, Kapelushnik J, Hershkovitz E. Thyroglossal duct carcinoma in children: case presentation and review of the literature. Thyroid 2004;14(9):777–785.

    Article  PubMed  Google Scholar 

  8. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 2001;25(12):1478–1484.

    Article  CAS  PubMed  Google Scholar 

  9. Hassoun AA, Hay ID, Goellner JR, Zimmerman D. Insular thyroid carcinoma in adolescents: a potentially lethal endocrine malignancy. Cancer 1997;79(5):1044–1048.

    Article  CAS  PubMed  Google Scholar 

  10. Ringel M, Levine MA. Current therapy for childhood thyroid cancer: optimal surgery and the legacy of King Pyrrhus. Ann Surg Oncol 2002;10:4–6.

    Article  Google Scholar 

  11. Bal CS, Padhy AK, Kumar A. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone. Nucl Med Commun 2001;22(8):881–887.

    Article  CAS  PubMed  Google Scholar 

  12. Arici C, Erdogan O, Altunbas H, et al. Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients. Horm Res 2002;57(5–6):153–156.

    Article  CAS  PubMed  Google Scholar 

  13. Kowalski LP, Goncalves Filho J, Pinto CA, Carvalho AL, de Camargo B. Long-term survival rates in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2003;129(7):746–749.

    Article  PubMed  Google Scholar 

  14. Cady B. Presidential address: beyond risk groups—a new look at differentiated thyroid cancer. Surgery 1998;124(6):947–957.

    CAS  PubMed  Google Scholar 

  15. Miccoli P, Antonelli A, Spinelli C, Ferdeghini M, Fallahi P, Baschieri L. Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 1998;133(1):89–93.

    Article  CAS  PubMed  Google Scholar 

  16. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 2005;12(4):773–803.

    Article  CAS  PubMed  Google Scholar 

  17. Zimmerman D, Hay ID, Gough IR, et al. Papillary thyroid cancer in children and adults: long-term follow-up of 1039 patients conservatively treated at one institute during three decades. Surgery 1988;104:1157–1166.

    CAS  PubMed  Google Scholar 

  18. Park H-M, Perkins OW, Edmondson JW, et al. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid 1994;4:49–54.

    Article  CAS  PubMed  Google Scholar 

  19. McDougall IR. 74MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancer. Nucl Med Commun 1997;18(6):505–512.

    Article  CAS  PubMed  Google Scholar 

  20. Park HM. 123I: almost a designer radioiodine for thyroid scanning. J Nucl Med 2002;43(1):77–78.

    CAS  PubMed  Google Scholar 

  21. Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med 2001;26(1):6–9.

    Article  CAS  PubMed  Google Scholar 

  22. Mazzaferri EL. Radioiodine and other treatments and outcomes. In: Braverman LE, Utiger RD, eds. Werner and Inbar’s The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:904–929.

    Google Scholar 

  23. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 2002;12(8):683–702.

    Article  PubMed  Google Scholar 

  24. Haveman JW, van Tol KM, Rouwe CW, Piers do A, Plukker JT. Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol 2003;10(1):15–20.

    Article  PubMed  Google Scholar 

  25. Chow SM, Law SC, Mendenhall WM, et al. Differentiated thyroid carcinoma in childhood and adolescence: clinical course and role of radioiodine. Pediatr Blood Cancer 2004;42(2):176–183.

    Article  PubMed  Google Scholar 

  26. Grigsby PW, Gal-or A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer 2002;95(4):724–729.

    Article  PubMed  Google Scholar 

  27. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39(9):1531–1536.

    CAS  PubMed  Google Scholar 

  28. Anger K, Feine U. Thyroid carcinoma in childhood. Prog Pediatr Surg 1983;16:39–42.

    CAS  PubMed  Google Scholar 

  29. Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297–306.

    Article  CAS  PubMed  Google Scholar 

  30. Sisson JC, Carey JE. Thyroid carcinoma with high levels of function: treatment with (131)I. J Nucl Med 2001;42(6):975–883.

    CAS  PubMed  Google Scholar 

  31. Sisson JC, Shulkin BL, Lawson S. Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I. J Nucl Med 2003;44(6):898–903.

    CAS  PubMed  Google Scholar 

  32. Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999;84(11):3877–3885.

    Article  CAS  PubMed  Google Scholar 

  33. Iorcansky S, Herzovich V, Qualey RR, Tuttle RM. Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer. J Clin Endocrinol Metab 2005;90(12):6553–6555.

    Article  CAS  PubMed  Google Scholar 

  34. Grigsby PW, Siegel BA, Baker S, Eichling JO. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. JAMA 2000;283(17):2272–2274.

    Article  CAS  PubMed  Google Scholar 

  35. Sisson JC, Giordano TJ, Jamadar DA, et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 1996;78(10):2184–2192.

    Article  CAS  PubMed  Google Scholar 

  36. Rosenbaum RC, Johnston GS, Valente WA. Frequency of hepatic visualization during I-131 imaging for metastatic thyroid carcinoma. Clin Nucl Med 1988;13(9):657–660.

    Article  CAS  PubMed  Google Scholar 

  37. Carlisle M, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun 2003;24:715–735.

    Article  CAS  PubMed  Google Scholar 

  38. Vini L, Hyer S, Al-Saadi A, Pratt B, Harmer C. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002;78(916):92–93.

    Article  CAS  PubMed  Google Scholar 

  39. Casara D. Rubello D, Saladini G, et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med 1993;20(3):192–194.

    Article  CAS  PubMed  Google Scholar 

  40. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995;36(1):21–27.

    CAS  PubMed  Google Scholar 

  41. Ayala C, Navarro E, Rodriguez JR, Silva H, Venegas E, Astorga R. Conception after iodine-131 therapy for differentiated thyroid cancer. Thyroid 1998;8(11):1009–1011.

    Article  CAS  PubMed  Google Scholar 

  42. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 1997;38(5):669–675.

    CAS  PubMed  Google Scholar 

  43. Hyer S, Vini L, O’Connell M, Pratt B, Harmer C. Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol (Oxf) 2002;56(6):755–758.

    Article  CAS  Google Scholar 

  44. Rall JE, Alpers JB, Lewallen CG, Sonenberg M, Berman M, Rawson RW. Radiation pneumonitis and fibrosis: a complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid. J Clin Endocrinol Metab 1957;17(11):1263–1276.

    Article  CAS  PubMed  Google Scholar 

  45. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol 2000;35(1):41–46.

    Article  CAS  PubMed  Google Scholar 

  46. Lee YM, Lo CY, Lam KY, Wan KY, Tarn PK. Well-differentiated thyroid carcinoma in Hong Kong Chinese patients under 21 years of age: a 35-year experience. J Am Coll Surg 2002;194(6):711–716.

    Article  PubMed  Google Scholar 

  47. Buckwalter JA, Thomas CG, Freeman JB. Is childhood thyroid cancer a lethal disease? Ann Surg 1975;181(5):632–639.

    Article  CAS  PubMed  Google Scholar 

  48. Jarzab B, Handkiewicz Junak D, Wloch J, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med 2000;27(7):833–841.

    Article  CAS  PubMed  Google Scholar 

  49. Zettinig G, Kaserer K, Passler C, Flores JA, Niederle B, Dudczak R. Advanced insular thyroid carcinoma in a fourteen-year-old girl: twenty-four years of follow-up. Thyroid 2000;10(5):435–437.

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

(2007). Differentiated Thyroid Cancer in Children. In: Thyroid Cancer in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84628-748-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-748-0_7

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-544-8

  • Online ISBN: 978-1-84628-748-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation